NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents - Test2 - elhamkhani - TriplyDB

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

http://www.wikidata.org/entity/Q33705075

about

Role of redoximiRs in fibrogenesis Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles Reactive oxygen species and fibrosis: further evidence of a significant liaison A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring.Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis.Therapeutic potential of NADPH oxidase 1/4 inhibitors.GPER modulators: Opportunity Nox on the heels of a class Akt.Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process.

P2860

Q26776555-65BDD935-6E19-4736-B54D-8E9C24A13990 Q26786129-05CB066F-1F4D-4D15-926D-2E5A60951896 Q28075551-FDE63D90-03A4-4A1D-8BAE-D90431CEF31E Q28077930-A717080D-167D-443E-938A-155E7573D2CB Q34479310-95B0D58E-14C0-4BCA-A143-C09970BB46A3 Q34486470-06061922-CAAE-42C5-A862-1FE772193456 Q35928666-B52440C3-4269-4E12-8232-FA8D15EA1DF4 Q38283226-C98D254A-5B6B-4B6F-9C95-C0F426B7CCA2 Q38858553-F025B75D-9019-48E9-A640-2A1CEB1CCCE5 Q39174507-0A0926D4-6CEB-4357-B054-CCD01829EA57 Q47282821-1FF4DE05-243D-4BB3-B579-8DEF737B1A56

P2860

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

http://www.wikidata.org/entity/Q33705075

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

@ast

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

@en

type

label

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

@ast

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

@en

prefLabel

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

@ast

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

@en

P1433

Q33705075-B58FA05B-84F3-4BFC-8A17-EE4F669D7B42

P1476

Q33705075-4C897C0C-4591-4D84-A63D-7947D1DD05E7

P2093

Q33705075-1099657E-DEEE-440E-8416-FD671FCC0085

Q33705075-C6D5DA27-8DF4-4E85-940E-53062942439E

Q33705075-F3842144-D5CB-4A60-822B-6364D2FCBA17

P2860

Q33705075-00319D4F-F281-4E8F-83AB-08FAFCA24C42

Q33705075-00BC5375-BC5D-4493-92E0-C15D4DED2CBD

Q33705075-013F7C81-AF65-4462-AEC5-EA6B50EF36EA

Q33705075-04558DE1-3D09-4043-8D04-C16D64B71676

Q33705075-04E8E144-A8FB-4FFB-B572-0F4BB6A57859

Q33705075-0A02C7C3-F998-4630-A65B-1FB3229277EA

Q33705075-0ACEB317-FB7C-4948-9F96-E32D3ED3EB4B

Q33705075-0B5FE5EF-F2AE-46DE-84A9-1058BA722B93

Q33705075-11434370-46CB-43CA-8A3C-5CD590A902AF

Q33705075-122ADAD7-52E2-48D1-8C9D-BD8AC6575AFB

P2888

Q33705075-C5EEC31C-3887-4B2E-9FA3-742B971A186B

P304

Q33705075-891B5498-ED92-45BB-99AA-AE315A82C6FB

P31

Q33705075-9901E8D1-CEAC-4D9E-82DA-695E861D011B

P356

Q33705075-6AE19C4F-0991-479F-9D77-E9B836A31410

P433

Q33705075-0EA3161B-1A27-4969-990F-2A0A14BD4C05

P478

Q33705075-9A3A56DA-D1F5-4C00-AECB-4F97E8E5BE35

P50

Q33705075-3594CA3B-86A0-4338-A2B1-01DC0D17F392

P577

Q33705075-07F50C66-89BE-45AD-8A6B-784874FEA064

P6179

Q33705075-C2D9051C-825E-40F6-BE06-9A3B84D9D1E5

P698

Q33705075-B64C2D78-E737-4F40-8306-5667F1B6ECB0

P932

Q33705075-F30079D5-8180-4552-B4CE-4C6E46A8B455

P356

S00403-013-1416-8

P1433

Archives of Dermatological Research

P1476

NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents

@en

P2093

Hadar Lev-Tov

http://www.w3.org/2001/XMLSchema#string

Jared Jagdeo

http://www.w3.org/2001/XMLSchema#string

Olubukola Babalola

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and molecular mechanisms of fibrosis

The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis

Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice.

Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease

Targeting NADPH oxidases in vascular pharmacology

TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities

Fibrotic and sclerotic manifestations of chronic graft-versus-host disease

CCN2 is required for bleomycin-induced skin fibrosis in mice

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

Telomere shortening may be associated with human keloids.

P2888

s00403-013-1416-8

P304

313-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00403-013-1416-8

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

306

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037317328

http://www.w3.org/2001/XMLSchema#string

P698

24155025

http://www.w3.org/2001/XMLSchema#string

P932

4043188

http://www.w3.org/2001/XMLSchema#string